If you need more lookups,
subscriptions start at $34 USD/month.
Anders Ekblom Location
Stockholm, SE
Anders Ekblom Work
2024 -now Director of the Board @ Synerkine Pharma
2023 -now Director of the Board @ Flerie Invest AB
2022 -now Chairman of the Board @ Atrogi AB, Sweden
2021 -now Chairman of the Board @
2015 -now Director of the Board @
2018 -2022 Vice Chairman Of The Board @
2016 -2018 Director of the Board @
2015 -2018 Chairman of the Board @
2012 -2014 Director of the Board @
2012 -2013 Global Head Science and Technology Integration, R and D @
2010 -2013 CEO AstraZeneca Sweden AB @
2009 -2011 Executive Vice President, Global Medicines Development, R and D @
2006 -2008 Vice President and Head, Global Clinical Development, Global Drug Development @
Anders Ekblom Education
Karolinska Institute
Associates (Physiology)
1993
Karolinska Institutet / Karolinska University Hospital
(Anesthesiology)
1993
Karolinska Institute
Doctor of Medicine (Medicine)
1986
Karolinska Institute
Doctor of Philosophy (Physiology)
1985
Karolinska Institute 1979
Anders Ekblom Skills
Clinical Trials
R&D
Clinical Development
Drug Development
Leadership
Pharmaceutical Industry
Biotechnology
Drug Discovery
Lifesciences
Neuroscience
Change Management
Technology Transfer
Oncology
Regulatory Affairs
CRO
Life Sciences
Pharmacovigilance
Strategy
Microsoft Excel
Research
Anders Ekblom Summary
Anders Ekblom, based in Stockholm, SE, is currently a Director of the Board at Synerkine Pharma. Anders Ekblom brings experience from previous roles at Flerie Invest AB, Atrogi AB, Sweden, XSPRAY PHARMA AB (PUBL) and MEREO BIOPHARMA GROUP PLC. Anders Ekblom holds a Associates in Physiology @ Karolinska Institute. With a robust skill set that includes Clinical Trials, R&D, Clinical Development, Drug Development, Leadership and more. Anders Ekblom has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Anders Ekblom?
Find contact details for 700 million professionals.